Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
Einfacher Volltextzugriff von (fast) überall
Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...
    Datensatz exportieren als...
  • BibTeX
244 PARP inhibitors
European journal of cancer supplements, 2010, Vol.8 (7), p.81-81
2010
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
168 Circulating tumour cells as biomarkers in clinical trials
European journal of cancer supplements, 2009, Vol.7 (2), p.42-43
2009
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
30 INVITED Patient enrichment strategy in phase II
European journal of cancer supplements, 2008, Vol.6 (12), p.13-13
2008
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
703 POSTER A phase I and pharmacokinetic (PK) study of BIBW 2992, an oral irreversible dual EGFR/HER2 inhibitor
European journal of cancer supplements, 2007-09, Vol.5 (4), p.108-108
2007
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
1255 Clinical and preclinical development of 4SC-201, a new oral histone deacetylase (HDAC) inhibitor
European journal of cancer supplements, 2009, Vol.7 (2), p.137-137
2009
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
45 Preliminary results of a phase 1 study of intravenous administration of GL-ONC1 vaccinia virus including green-fluorescent protein real time imaging in patients with advanced cancer
European journal of cancer supplements, 2010, Vol.8 (7), p.23-23
2010
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
362 First in human trial of a poly(ADP)-ribose polymerase (PARP) inhibitor MK-4827 in advanced cancer patients (p) with antitumor activity in BRCA-deficient and sporadic ovarian cancers
European journal of cancer supplements, 2010, Vol.8 (7), p.114-115
2010
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
405 A mass balance study to investigate the metabolism, excretion and pharmacokinetics of [14C]-olaparib (AZD2281) in patients with advanced solid tumours refractory to standard treatments
European journal of cancer supplements, 2010, Vol.8 (7), p.128-129
2010
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
1203 Pharmacokinetic and pharmacodynamic Phase I trial of ARQ 197 incorporating dynamic contrast-enhanced (DCE) and diffusion weighted (DW) magnetic resonance imaging (MRI) studies investigating the antiangiogenic and antitumor activity of selective c-Met inhibition
European journal of cancer supplements, 2009, Vol.7 (2), p.121-121
2009
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
1235 A phase-I study of the combination of intravenous reovirus (REOLYSIN ®) and gemcitabine in patients with advanced cancer
European journal of cancer supplements, 2009, Vol.7 (2), p.131-131
2009
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
386 POSTER Pharmacokinetic (PK) and pharmacodynamic (PD) phase I study of an oral c-Met inhibitor ARQ197 reaches maximum tolerated dose (MTD) in a twice daily (bid) dosing schedule
European journal of cancer supplements, 2008, Vol.6 (12), p.121-121
2008
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
126 INVITED New drug treatment for cancer in 2007 – real progress at last?
European journal of cancer supplements, 2007, Vol.5 (4), p.35-35
2007
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
159 POSTER Re-inducing sensitivity to abiraterone acetate, a novel CYP17 inhibitor with a high level of anti-tumour activity in castration resistant prostrate cancer
European journal of cancer supplements, 2008, Vol.6 (12), p.51-51
2008
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
655 Preliminary report of efficacy of abiraterone acetate in patients with estrogen (ER) or androgen receptor (AR) positive, advanced breast carcinoma resistant to standard endocrine therapies
European journal of cancer supplements, 2010, Vol.8 (7), p.204-205
2010
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
431 POSTER A phase I first-in-human study of the polo-like kinase 1-selective inhibitor, GSK461364, in patients with advanced solid tumors
European journal of cancer supplements, 2008, Vol.6 (12), p.135-136
2008
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
565 POSTER Activity of the anti-IGF-IR antibody CP-751,871 in combination with docetaxel as first-line treatment for castration resistant prostate cancer in a randomized Phase II trial
European journal of cancer supplements, 2008, Vol.6 (12), p.178-178
2008
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
213 POSTER Phase II multicenter trial of belinostat (PXD101) in combination with carboplatin and paclitaxel (BelCaP) for patients (pts) with transitional cell carcinoma (TCC) of the bladder
European journal of cancer supplements, 2008, Vol.6 (12), p.67-68
2008
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
388 POSTER Safety, pharmacokinetics and preliminary activity of the anti-IGF-IR antibody CP-751,871 in patients with sarcoma
European journal of cancer supplements, 2008, Vol.6 (12), p.122-122
2008
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
573 POSTER Phase I study of BIBW2992, an oral irreversible dual EGFR/HER2 inhibitor, showing activity in tumors with mutated EGFR
European journal of cancer supplements, 2006-11, Vol.4 (12), p.173-174
2006
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
348 POSTER A phase I study of wild-type reovirus, which selectively replicates in cells expressing activated Ras, administered intravenously to patients with advanced cancer
European journal of cancer supplements, 2006-11, Vol.4 (12), p.108-108
2006
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
196 POSTER A phase I trial incorporating the pharmacodynamic (PD) study of circulating tumour cells (CTC) of CP-751,871 (C), a monoclonal antibody against the insulin-like growth factor 1 receptor (IGF-1R), in combination with docetaxel (D) in patients (p) with advanced cancer
European journal of cancer supplements, 2006-11, Vol.4 (12), p.61-62
2006
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
503 POSTER Phase I pharmacokinetic (PK) and pharmacodynamic (PD) evalutation of an oral small molecule inhibitor of Poly ADP-Ribose Polymerase (PARP), Ku in patients (p) with advance tumours
European journal of cancer supplements, 2006-11, Vol.4 (12), p.153-153
2006
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
197 A phase I and pharmacokinetic (PK) study of an agonistic, fully human monoclonal antibody, HGS-ETR2, to the TNF-alpha related apoptosis inducing ligand receptor 2 (TRAIL R2) in patients with advanced cancer
European journal of cancer supplements, 2004-09, Vol.2 (8), p.61-61
2004
Volltextzugriff (PDF)
1 – 23 von 23
Suche als RSS-Feed
Aktive Filter
Zeitschrift / SerieEuropean Journal Of Cancer Supplements
Suchergebnisse filtern
Filter anzeigen